Colorectal Cancer Treated With Adjuvant Regorafenib Versus Placebo After Curative Treatment of Liver Metastases in a Randomized, Double-blind, Placebo-Controlled Phase-III STudy
Clinical trial NCT01939223 · TERMINATED
Trial details
- NCT number
- NCT01939223
- Sponsor
- Bayer
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2013-12-02
- Primary completion
- 2016-08-29
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.